BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Doxorubicin
,
rs2230926
,
LEP
,
Apoptosis
,
Arthritis
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NA 36
Summary
General Info
Curated Studies
Most Correlated Studies
Early and sustained innate immune response to highly pathogenic influenza virus
Botulinum neurotoxin A induced expression profiles in Raw264.7 cells
Liver biopsies of hepatitis C virus-infected hepatocellular carcinoma patients
Gastric cancer cell lines YCC3, AGS, and KATOIII with KLF5, GATA4, or GATA6 knockdown
Breast adenocarcinoma MCF7 cells with PTH-rp overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
Physicochemical properties of the modeled structure of astacin metalloprotease moulting enzyme NAS-3…
The astacin metalloprotease moulting enzyme NAS-36 is required for normal cuticle ecdysis in free-li…
Compartment syndrome-induced muscle injury is diminished by the neutralization of pro-inflammatory c…
Instrument for precision long-term β-decay rate measurements.
Maternal methadone treatment and neonatal abstinence syndrome.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Clas…
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ